US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 10.790
  • -0.360-3.23%
Close Dec 27 16:00 ET
  • 10.790
  • 0.0000.00%
Post 20:01 ET
1.05BMarket Cap-21.58P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
575.00K
2.07M
+1.49M
Beat Est.
--
--
+259.65%
EPS
-0.15
-0.20
-0.05
Miss Est.
+7.82%
-25.00%
-35.69%
Analyst Rating
Buy

Dec 5, 2024

ARS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.028M--
--2024/Q4-- / 17.077M--
Nov 13, 20242024/Q32.068M / 575.000K--
--2024/Q2500.000K / 666.670K--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.028M--
--2024/Q4-- / 17.077M--
Nov 13, 20242024/Q32.068M / 575.000K--
--2024/Q2500.000K / 666.670K--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

ARS Pharmaceuticals Earnings Reports

  • ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Dec 6 16:10 ET

  • ARS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 13 07:08 ET

  • ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 13 07:03 ET

  • ARS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 5, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data